XSpray Pharma (Sweden) Probability of Future Stock Price Finishing Over 48.55
| XSPRAY Stock | SEK 43.00 1.00 2.27% |
XSpray |
XSpray Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of XSpray Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for XSpray Pharma AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| XSpray Pharma AB generated a negative expected return over the last 90 days | |
| XSpray Pharma AB has high historical volatility and very poor performance | |
| XSpray Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (96.7 M) with profit before overhead, payroll, taxes, and interest of 656 K. | |
| XSpray Pharma AB has accumulated about 192.85 M in cash with (51.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.79. | |
| Roughly 47.0% of the company outstanding shares are owned by insiders |
XSpray Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of XSpray Stock often depends not only on the future outlook of the current and potential XSpray Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. XSpray Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 19.2 M | |
| Cash And Short Term Investments | 271.9 M |
XSpray Pharma Technical Analysis
XSpray Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. XSpray Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of XSpray Pharma AB. In general, you should focus on analyzing XSpray Stock price patterns and their correlations with different microeconomic environments and drivers.
XSpray Pharma Predictive Forecast Models
XSpray Pharma's time-series forecasting models is one of many XSpray Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary XSpray Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about XSpray Pharma AB
Checking the ongoing alerts about XSpray Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for XSpray Pharma AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| XSpray Pharma AB generated a negative expected return over the last 90 days | |
| XSpray Pharma AB has high historical volatility and very poor performance | |
| XSpray Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (96.7 M) with profit before overhead, payroll, taxes, and interest of 656 K. | |
| XSpray Pharma AB has accumulated about 192.85 M in cash with (51.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.79. | |
| Roughly 47.0% of the company outstanding shares are owned by insiders |
Other Information on Investing in XSpray Stock
XSpray Pharma financial ratios help investors to determine whether XSpray Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XSpray with respect to the benefits of owning XSpray Pharma security.